+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
FEMALE
Healthy Volunteers
ID03276923

Registry Study for Pregnant Women with Autoimmune and Rheumatic Diseases Tracking Pregnancy and Baby Health Outcomes

Led by Duke University · Updated on 2026-01-08

1000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are enrolling pregnant women or those planning pregnancy within 6 months who have autoimmune and rheumatologic diseases. The study aims to better understand risk factors related to increased inflammation before and during pregnancy that may affect the health of both mothers and their babies. This registry study collects data over several years to help improve outcomes for women with rheumatic diseases. Participants will remain under the care of their own rheumatologist and obstetrician throughout pregnancy. This observational study does not involve extra treatments, medications, lab tests, or procedures outside standard care. Data from routine office visits during pregnancy and for up to 12 months after delivery will be collected and analyzed periodically. Women enrolled will provide health information through their regular medical visits without added risks. Researchers will track outcomes related to pregnancy risks using tools like the MADRA-DAP questionnaire over up to 10 years. The study is ongoing with periodic reviews to better define factors influencing pregnancy health in women with autoimmune diseases.

CONDITIONS

Brief Title

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Research Team

L

Laura Neil

E

Edna Scarlett

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here